![Ilan Lior](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ilan Lior
Director/Board Member at Nucleix Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Danny Frumkin | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 16 years |
Christopher Richard Hibberd | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 5 years |
Erez Chimovits | M | 60 |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 5 years |
Adam Wasserstrom | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 16 years |
Yinon Brosh | M | - |
Aurum Ventures MKI Ltd.
![]() Aurum Ventures MKI Ltd. Investment ManagersFinance Aurum Ventures MKI Ltd (Aurum Ventures) is a venture capital subsidiary of Morris Kahn founded in 1998 by Morris Kahn. The firm is headquartered in Tel Aviv, Israel. | 8 years |
Heiner Dreismann | M | 69 |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 8 years |
Morris Kahn | M | 94 |
Aurum Ventures MKI Ltd.
![]() Aurum Ventures MKI Ltd. Investment ManagersFinance Aurum Ventures MKI Ltd (Aurum Ventures) is a venture capital subsidiary of Morris Kahn founded in 1998 by Morris Kahn. The firm is headquartered in Tel Aviv, Israel. | 26 years |
Nir Dror | M | 48 |
Aurum Ventures MKI Ltd.
![]() Aurum Ventures MKI Ltd. Investment ManagersFinance Aurum Ventures MKI Ltd (Aurum Ventures) is a venture capital subsidiary of Morris Kahn founded in 1998 by Morris Kahn. The firm is headquartered in Tel Aviv, Israel. | 11 years |
Thomas Buchholz | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 4 years |
Fred Witjes | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | - |
Maria Ribal | F | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | - |
Martin Tammemägi | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Opher Shapira | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | - |
Jean-Marc Hagai | M | - |
Aurum Ventures MKI Ltd.
![]() Aurum Ventures MKI Ltd. Investment ManagersFinance Aurum Ventures MKI Ltd (Aurum Ventures) is a venture capital subsidiary of Morris Kahn founded in 1998 by Morris Kahn. The firm is headquartered in Tel Aviv, Israel. | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Israel | 14 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ilan Lior
- Personal Network